[Dihydromyricetin improves Parkinson's disease-like lesions in T2DM rats by activating AMPK/ULK1 pathway].

Li, Qi; Chen, Nian; Luo, Jin-Ding; Wu, Hui-Lin; Wang, Zi-Han; Li, Meng-Wei; Feng, Shui-Dong; Ling, Hong-Yan

Li, Qi; Chen, Nian; Luo, Jin-Ding; Wu, Hui-Lin; Wang, Zi-Han; Li, Meng-Wei; Feng, Shui-Dong; Ling, Hong-Yan.

Afiliação

Li Q; Department of Physiology, Hengyang Medical College, University of South China, Hengyang 421001, China.
Chen N; Department of Medical Cosmetology, the First Affiliated Hospital, University of South China, Hengyang 421001, China.
Luo JD; Department of Physiology, Hengyang Medical College, University of South China, Hengyang 421001, China.
Wu HL; Clinical Medicine Class 10, Grade 2018, Hengyang Medical College, University of South China, Hengyang 421001, China.
Wang ZH; Department of Physiology, Hengyang Medical College, University of South China, Hengyang 421001, China.
Li MW; Department of Physiology, Hengyang Medical College, University of South China, Hengyang 421001, China.
Feng SD; Department of Social Medicine and Health Management, School of Public Health, University of South China, Hengyang 421001, China. shuidong-f@hotmail.com.
Ling HY; Department of Physiology, Hengyang Medical College, University of South China, Hengyang 421001, China. linghongyan0203@126.com.

Sheng Li Xue Bao ; 75(1): 59-68, 2023 Feb 25.

Article em Zh | MEDLINE | ID: mdl-36859835

Assuntos

Diabetes Mellitus Tipo 2; Doença de Parkinson; Ratos; Animais; Ratos Sprague-Dawley; Proteínas Quinases Ativadas por AMP; Proteína Homóloga à Proteína-1 Relacionada à Autofagia

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Diabetes Mellitus Tipo 2 Limite: Animals Idioma: Zh Revista: Sheng Li Xue Bao Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Buscar no Google

Imprimir

XML

PubMed Links